Olanib is a generic version of LYNPARZA which is a targeted cancer drug used to treat advanced or recurrent ovarian cancer, early or metastatic breast cancer, metastatic pancreatic cancer, and also metastatic prostate cancer.
Olanib is a targeted therapy that works by targeting cancer cell pathways. It is a poly (ADP-ribose) polymerase inhibitor, also referred to as a PARP inhibitor.

PARP helps cells, including
cancer cells, survive and grow

PARP is a protein that helps repair
DNA damage in cells so they can
survive. In cancer cells, you want to
stop this repair so they can’t survive.

Olaparib may help
block the activity of PARP

Olaparib helps to kill cancer cells by
preventing PARP from repairing their
DNA. PARP is also found in healthy
cells, so Olaparib may affect them
too.